SINOVA-M-14037 Cardiac Troponin I (cTnI) Quantitative Test Kit

Clinical Significance: Cardiac Troponin I (cTnI) can detect minor myocardial damage and is one of the most sensitive and specific markers of myocardial cell injury. It is widely recognized for the rapid diagnosis of Acute Myocardial Infarction (AMI) and Acute Coronary Syndromes (ACS). cTnI also assists in risk stratification of ACS and reflects its prognosis as a primary biochemical marker.
Product Specifications: 20 tests/box
Product Shelf Life: 18 months when sealed in an aluminum foil pouch. Use within 1 hour after opening the pouch.
Product Storage: Store the test card at 2℃-30℃.
 
Usage Scenarios:
Emergency Departments: For rapid diagnosis of Acute Myocardial Infarction (AMI) and Acute Coronary Syndromes (ACS).
Cardiology Departments: For detecting minor myocardial damage, assessing myocardial injury, and risk stratification of ACS.
Hospitals and Clinics: For monitoring and managing patients with chest pain and other symptoms indicative of cardiac events.
Diagnostic Laboratories: For routine testing of cardiac Troponin I (cTnI) levels to evaluate heart health and injury.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic tools are used for comprehensive cardiac care.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are expanding cardiac diagnostic and treatment capabilities.
Global Health Programs: International health initiatives focused on improving the diagnosis and management of cardiac conditions in low-resource settings.